Ovarian cancer cell cluster inhibits pancreatic cancer progression
Cui, Q.
Show abstract
Pancreatic cancer is the most lethal cancer and all of the current cancer treatment strategies fail at this disease. It is thus urgently important to explore novel therapeutics. We previously revealed that it can be significantly inhibited by ovarian cancer cell by both in vitro and in vivo experiments. It was reported that cancer cell cluster can greatly enhance the efficiency in metastasis model compared to single cancer cell. Given this observation, here we proposed that ovarian cancer cell cluster could inhibit pancreatic cancer more efficiently than single ovarian cancer cell. As a result, animal experiments demonstrated that the injection of both low and high doses of SKOV3 ovarian cancer cluster show significantly higher efficiency in inhibiting pancreatic cancer xenografts than single SKOV3 ovarian cancer cell. Moreover, single cell RNA-sequencing analysis revealed that ovarian cancer cell cluster treatment inhibited pancreatic cancer by promoting inflammation response by both activating the NF-{kappa}B pathway in pancreatic cancer cells and substantially shifting macrophages in tumor microenvironments (TME) to M1 phenotype. In summary, this study proposed and validated a novel potential therapeutic for pancreatic cancer.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model 95%
- Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing 95%
- A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer 95%
Similar papers in this journal
- Establishment of a prognosis prediction model based on pyroptosis-related signatures associated with the immune microenvironment and molecular heterogeneity in clear cell renal carcinoma 95%
- Pyroptosis-related gene signatures can robustly diagnose skin cutaneous melanoma and predict the prognosis 94%
- BNIP3 upregulation characterizes cancer cell subpopulation with increased fitness and proliferation 94%
Similar papers in this journal
- SARS-CoV-2-Triggered Mast Cell Rapid Degranulation Induces Alveolar Epithelial Inflammation and Lung Injury 92%
- Vertical RAS-pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations 91%
- Astrocytic MAOB-GABA axis as a molecular brake on repair following spinal cord injury 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.